Returns
Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.
Showing returns filed by GSK .
Filed returns
26
match these filters
| Period | Registrant | Policy area | Subject, as filed | Officials named | Link |
|---|---|---|---|---|---|
| Sep–Dec 2026 | GSK | Health | HIV Policy (Public policy or programme) | 2 | On lobbying.ie |
| May–Aug 2026 | GSK | Health | Vaccines policy (Public policy or programme) | 21 | On lobbying.ie |
| May–Aug 2026 | GSK | Health | Vaccines policy (Public policy or programme) | 10 | On lobbying.ie |
| Jan–Apr 2026 | GSK | Health | Adult immunisation policy (Public policy or programme) | 10 | On lobbying.ie |
| Jan–Apr 2026 | GSK | Health | HIV treatment and prevention (Public policy or programme) | 3 | On lobbying.ie |
| Sep–Dec 2025 | GSK | Health | Information regarding HIV in Ireland (Public policy or programme) | 3 | On lobbying.ie |
| Sep–Dec 2025 | GSK | Health | Shingles Immunisation policy (Public policy or programme) | 10 | On lobbying.ie |
| Sep–Dec 2025 | GSK | Health | Immunisation against RSV (Public policy or programme) | 11 | On lobbying.ie |
| May–Aug 2025 | GSK | Health | Vaccination policy (Public policy or programme) | 20 | On lobbying.ie |
| May–Aug 2025 | GSK | Health | Investment in treatment of HIV (Public policy or programme) | 9 | On lobbying.ie |
| May–Aug 2025 | GSK | Health | Access and reimbursement timelines for medicines (Public policy or programme) | 2 | On lobbying.ie |
| May–Aug 2025 | GSK | EU Affairs | Meeting to discuss themes for Ireland's Council Presidency (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2025 | GSK | Health | Immunisation policy (Public policy or programme) | 23 | On lobbying.ie |
| Sep–Dec 2024 | GSK | Health | Adult, RSV and Shingles Vaccination policy (Public policy or programme) | 6 | On lobbying.ie |
| Sep–Dec 2024 | GSK | Health | Vaccination policy (Public policy or programme) | 9 | On lobbying.ie |
| Sep–Dec 2024 | GSK | Health | To demonstrate return on investment from adult vaccination (Public policy or programme) | 22 | On lobbying.ie |
| May–Aug 2024 | GSK | Health | Update on reimbursement process for Jemperli (Matters involving public funds) | 2 | On lobbying.ie |
| May–Aug 2024 | GSK | Health | Adult vaccination (Public policy or programme) | 193 | On lobbying.ie |
| Jan–Apr 2024 | GSK | Health | Immunisation policy (Public policy or programme) | 10 | On lobbying.ie |
| Jan–Apr 2024 | GSK | Health | Immunisation policy (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2023 | GSK | Health | Immunisation policy (Public policy or programme) | 15 | On lobbying.ie |
| May–Aug 2023 | GSK | Health | Immunisation policy (Public policy or programme) | 6 | On lobbying.ie |
| Sep–Dec 2020 | GSK | Foreign Affairs | Request to Minister for Foreign Affairs Simon Coveney seeking clear guidance on the Northern Ireland Protocol (Legislation) | 5 | On lobbying.ie |
| Sep–Dec 2020 | GSK | Environment | GSK's sustainability commitment and how it relates to the Dungarvan manufacturing site (Public policy or programme) | 4 | On lobbying.ie |
| Jan–Apr 2019 | GSK | Health | No specific piece of legislation. Rather a meeting around Slainte Care and chronic disease management (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2017 | GSK | EU Affairs | Brexit Implications (Public policy or programme) | 2 | On lobbying.ie |
Policy areas in these returns
| Public policy area | Filed returns | Share | Relative to the largest |
|---|---|---|---|
| Health | 22 | 84.6% | |
| EU Affairs | 2 | 7.7% | |
| Environment | 1 | 3.8% | |
| Foreign Affairs | 1 | 3.8% |